Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Basik

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Journal of Leukocyte Biology|April 13, 2004
Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gammaOmbretta Salvucci, Mark Basik, Lei Yao, et al.
Cancer Research|August 9, 2003
Widespread bimodal intrachromosomal genomic instability in sporadic breast cancers associated with 13q allelic imbalanceEwa Przybytkowski, Sonia Girouard, Brigitte Allard, et al.
Methodsx|August 14, 2023
A micro-flow, high-pH, reversed-phase peptide fractionation and collection system for targeted and in-depth proteomics of low-abundance proteins in limiting samplesMarta Zurawska, Mark Basik, Adriana Aguilar-Mahecha, et al.
Social Science & Medicine (1982)|April 29, 2014
Testing devices or experimental systems? Cancer clinical trials take the genomic turnNicole C Nelson, Peter Keating, Alberto Cambrosio, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
Ultradense array CGH and discovery of micro-copy number alterations and gene fusions in the cancer genomeEwa Przybytkowski, Adriana Aguilar-Mahecha, Sheida Nabavi, et al.
Proteome Science|April 8, 2009
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarkerAdriana Aguilar-Mahecha, Christiane Cantin, Maureen O'Connor-McCourt, et al.
Genes, Chromosomes & Cancer|June 4, 2011
Knockdown of RARB2 identifies a dual role in cancerJane J Pappas, André Toulouse, Mark Basik, et al.
Plos One|June 16, 2012
The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokinesAdriana Aguilar-Mahecha, Michael A Kuzyk, Dominik Domanski, et al.
Social Science & Medicine (1982)|November 26, 2021
Healthcare policy by other means: Cancer clinical research as "oncopolicy"Alberto Cambrosio, Jonah Campbell, Peter Keating, et al.
BMC Cancer|April 18, 2015
A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancerAbdel Nasser Hosein, Julie Livingstone, Marguerite Buchanan, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Journal of Leukocyte Biology|April 13, 2004
Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gammaOmbretta Salvucci, Mark Basik, Lei Yao, et al.
Cancer Research|August 9, 2003
Widespread bimodal intrachromosomal genomic instability in sporadic breast cancers associated with 13q allelic imbalanceEwa Przybytkowski, Sonia Girouard, Brigitte Allard, et al.
Methodsx|August 14, 2023
A micro-flow, high-pH, reversed-phase peptide fractionation and collection system for targeted and in-depth proteomics of low-abundance proteins in limiting samplesMarta Zurawska, Mark Basik, Adriana Aguilar-Mahecha, et al.
Social Science & Medicine (1982)|April 29, 2014
Testing devices or experimental systems? Cancer clinical trials take the genomic turnNicole C Nelson, Peter Keating, Alberto Cambrosio, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
Ultradense array CGH and discovery of micro-copy number alterations and gene fusions in the cancer genomeEwa Przybytkowski, Adriana Aguilar-Mahecha, Sheida Nabavi, et al.
Proteome Science|April 8, 2009
Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarkerAdriana Aguilar-Mahecha, Christiane Cantin, Maureen O'Connor-McCourt, et al.
Genes, Chromosomes & Cancer|June 4, 2011
Knockdown of RARB2 identifies a dual role in cancerJane J Pappas, André Toulouse, Mark Basik, et al.
Plos One|June 16, 2012
The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokinesAdriana Aguilar-Mahecha, Michael A Kuzyk, Dominik Domanski, et al.
Social Science & Medicine (1982)|November 26, 2021
Healthcare policy by other means: Cancer clinical research as "oncopolicy"Alberto Cambrosio, Jonah Campbell, Peter Keating, et al.
BMC Cancer|April 18, 2015
A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancerAbdel Nasser Hosein, Julie Livingstone, Marguerite Buchanan, et al.
Pageof 13